Antony Riley Net Worth & Insider Trades
Antony Riley - Chief Financial Officer, Forte Biosciences, Inc
What is Antony Riley's Net Worth?
The current estimated net worth of Forte Biosciences, Inc's Chief Financial Officer, Antony Riley, is estimated to be about $809.88K . Antony Riley owns about 11,065 units of Forte Biosciences, Inc common stock. In the last 3 years at Forte Biosciences, Inc, Antony Riley has sold an estimated value of $112.75K worth.
What is Antony Riley's Past Insider Trading?
Antony Riley's largest purchase order was 6,700 units , worth over $96.45K on June 30, 2020. Antony Riley's largest sale order was 25,000 units , worth over $106.11K on September 7, 2021. In total, Antony Riley has made about 8 transactions over 3 years of their time at Forte Biosciences, Inc. Antony Riley usually trades in April, with the busiest year in 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Antony Riley
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Antony Riley's Salary in 2020?
As Chief Financial Officer of Forte Biosciences, Inc, Antony Riley has a total base salary of $264,075 . Antony Riley received compensation valued at about $1,056,250 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $110,000 , option awards of $682,175 , and
What is Antony Riley's' Mailing Address?
- Mailing address is C/o Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 94538 PA
Forte Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Paul A. Wagner, Ph.D. | 2020 | $452,917 | $324,000 | - | - | - | $776,917 |
| Paul A. Wagner, Ph.D. | 2019 | $350,000 | $175,000 | - | - | - | $525,000 |
| Marty J. Duvall | 2020 | $233,731 | - | $76,920 | - | $862,899 | $1,173,550 |
| Marty J. Duvall | 2019 | $515,000 | - | - | $1,257,437 | $474 | $1,772,911 |
| Antony Riley | 2020 | $264,075 | $110,000 | - | $682,175 | - | $1,056,250 |
| Antony Riley | 2019 | - | - | - | - | - | - |
| Mark Foletta | 2020 | $180,000 | - | $51,275 | - | $458,686 | $689,961 |
| Mark Foletta | 2019 | $388,308 | - | - | $592,443 | $360 | $981,111 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1419041/000119312521144995/d341393ddef14a.htm
What are Forte Biosciences, Inc's Past Insider Trades?
Forte Biosciences, Inc's most recent insider trade came on December 19, 2022 by Paul A Wagner who bought 100,000 units worth $104.67K . In the last 2 years, insiders at Forte Biosciences, Inc have sold an estimated value of $4.48M and bought an estimated value of $1.09M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Paul A Wagner, See Remarks, Antony Riley, Chief Financial Officer, and Allen Donald Williams, Director .
Forte Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||